11/5/2026

speaker
Janelle
Conference Operator

Good day and thank you for standing by. Welcome to the Q3 Nu Skin Enterprises Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, VP of Investor Relations, BG Hunt. Please go ahead.

speaker
BG Hunt
Vice President of Investor Relations

Thanks, Janelle, and good afternoon, everyone. I'm joined by Ryan Napierski, President and CEO, and by our interim CFO, Chelsea Lantz. Today, we'll be sharing Nu Skin's Q3 2026 results and providing guidance for the remainder of the year. Before I turn the Time over to Ryan. Let me point out that on today's call, comments will be made that include forward-looking statements. These statements involve important risks and uncertainties, and actual results may differ materially from those discussed or anticipated. Please refer to today's earnings release and our SEC filing for complete discussion of these risks. Also during the call, certain financial numbers may be discussed that differ from Comparable numbers obtained in our financial statements. We believe these non-GAAP numbers assist in comparing period-to-period results in a more consistent manner. Please refer to our investor website, ir.newskin.com, for any required reconciliation of these non-GAAP numbers. And with that, I'd like to now turn the call over to Ryan.

speaker
Ryan Napierski
President and Chief Executive Officer

Thanks, BG. Good afternoon, everyone. Thanks for joining for our third quarter call. We delivered revenue of $311 million. and adjusted EPS of $0.10, both within our guidance range. Our RISE manufacturing platform had an exceptional quarter, posting strong year-over-year revenue growth. While our results reflect ongoing pressures in the core business, we remain focused on our strategic priorities that we've outlined over the last year. Our Chief Operating Officer, Chayce Clark, has been leading the team to simplify, focus and execute upon each of them. These priorities are, number one, advancing our integrated anti-aging platform. Number two, strengthening our channel through improved Salesforce activation and development. Three, preparing for our formal launch of India early next year. And four, improving our operating model to support greater profitability over time. Let me briefly update you on each of these priorities. First, we continue to make progress in advancing our integrated anti-aging platform with Prism.io playing an increasingly important role in our approach to personalized wellness. Prism.io is designed to help consumers better understand their nutritional health status and engage more consistently with our wellness product solutions, creating a differentiated experience that connects technology, products, and ongoing customer relationships. Since launching Prism, through the end of Q3, we've now placed approximately 41,000 devices globally and completed 4.5 million scans. During the quarter, we rolled out version 2.0 of the app, which delivers a meaningfully improved user experience powered by our new intelligence AI integration. Since the app update, we've more than doubled our scan-to-purchase conversion rate to 10%, which tells us that the consumers are taking action when we get them more engaged with the platform. We also see this in demand for LifePak, our flagship nutritional supplement as sales grew nearly 3% year to date, a meaningful proof point given the broader revenue environment. We remain encouraged by the potential of this intelligent wellness platform to deepen customer engagement, support recurring product consumption, and provide our sales leaders with meaningful differentiation in the marketplace. In September, we hosted our global Nu Skin Life convention in Yokohama, Japan with approximately 12,000 sales leaders from around the world. We previewed upcoming innovations in our anti-aging portfolio with a particular focus on women's health, which will begin rolling out mid-2027. We will share our future product pipeline plans with you as we move into next year. We continue to invest in the capabilities necessary to strengthen our talented and committed global sales channel. We recognize that innovative products alone are not enough to drive sustainable growth. Equally important is our ability to empower our dedicated brand affiliates and sales leaders to effectively introduce our products, engage with our customers and build successful businesses. Over the past several years, we've focused on improving the simplicity, accessibility, and effectiveness of our sales compensation incentive system. We have also begun expanding our investments into leadership, learning, and development by providing unique opportunities for leaders to acquire and strengthen critical success capabilities in selling products, acquiring customers and brand affiliates, building sales teams, and leading large organizations. At Live, we held a dedicated leadership training session with industry-renowned trainer Eric Worre and our Team Elite top sales leaders. We've also just wrapped up a two-day leadership management event or management mastermind event earlier this week with nearly 2,000 of our most engaged sales leaders from around the globe. These investments are designed to further empower our talented sales leaders and strengthen their development of the next generation of leadership for Nu Skin. Although our overall customer and sales metrics remain under pressure, we believe these new investments are important to rebuilding engagement and productivity, which is the foundation for more sustainable performance in our channel into the future. Third, we continue to prepare for our anticipated formal launch of India during the first half of 2027. India represents an attractive long-term market opportunity supported by its large consumer population, Growing interest in health and wellness and an expanding entrepreneurial economy. We've acquired many learnings during our pre-marketing period and our teams are focused now on refining operational, product, and commercial preparations necessary to support a successful and scalable full market launch. We are approaching this opportunity with a long-term perspective as we focus on building the right foundation for sustainable growth. and finally, we remain focused on improving efficiency and profitability of our global business. As we continue to align our operations with current market conditions, we're evaluating opportunities to simplify our organization, improve productivity and better leverage our global capabilities. Chayce is also leading an effort across the company to realign the organization around our east-west structure which will enable the company to meet the unique needs of our business across these two hemispheres. Each region is now focused on building and executing successful go-to-market plans including incentive roadmaps, product introductions, and promotions in order to improve customer and affiliate acquisition and retention. We believe that aligning our organization around this east-west structure will also result in greater efficiencies in cost performance as we leverage our manufacturing hubs in both the U.S. for our Western market needs and China to better serve our Eastern markets. Moving manufacturing closer to the customer is expected to improve gross margin, speed to market, and fixed cost optimization over time. While there is more work ahead, we believe disciplined execution against these priorities will help the company improve efficiencies and profitability as our business performance strengthens. Looking ahead to the fourth quarter, our focus remains on driving customer and affiliate engagement through the holiday seasons as we anticipate sequential revenue growth. As we prepare for 2027, we remain committed to the strategic priorities we've outlined throughout the year. Again, advancing our anti-aging platform, strengthening our sales channel, preparing for India's formal launch, and improving our operating efficiency. We believe these initiatives position Nu Skin for improved performance and sustainable growth long term. So with that, I'll turn the time over to Chelsea to review our financials.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API